CELLIBRIUM BIOSCIENCES

Trademark usage description

pharmaceutical preparations for the treatment of neurological diseases, namely, alzheimer's, amyotrophic lateral sclerosis (als), parkinson's disease, Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease, multiple sclerosis, and myasthenia gravis and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries

Classification kind code

Class [042]
Pharmaceutical research and development; Research and development services in the field of cell therapy

Classification kind code

Mark Details

Serial Number

2155281

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 17^th Feb 2025	Search Recorded
Submitted for opposition 67 on 27^th Sept 2024	Agent Name Changed
Submitted for opposition 287 on 13^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 20^th Dec 2021	Filed
Submitted for opposition 1 on 20^th Dec 2021	Created
Submitted for opposition 31 on 20^th Dec 2021	Formalized

CELLIBRIUM BIOSCIENCES

Classification Information

Classification kind code

Class [042]Pharmaceutical research and development; Research and development services in the field of cell therapy

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Pharmaceutical research and development; Research and development services in the field of cell therapy